These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18205099)

  • 1. Comparison of high- versus low-tissue affinity ACE-inhibitor treatment on circulating aldosterone levels in patients with chronic heart failure.
    Vittorio TJ; Ahuja K; Kasper M; Turalic H; Tseng CH; Jorde UP; Go C
    J Renin Angiotensin Aldosterone Syst; 2007 Dec; 8(4):200-4. PubMed ID: 18205099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Level of angiotensin II and aldosterone in plasma is often elevated in patients with heart failure treated with converting enzyme inhibitors--preliminary results].
    Grzybowski J; Bilińska ZT; Janas J; Michalak E; Skwarek M; Ruzyłło W
    Przegl Lek; 2002; 59(8):587-9. PubMed ID: 12638326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lisinopril in the treatment of congestive heart failure.
    Giles TD
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():83-7. PubMed ID: 2550647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Madej A; Olsson K
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is addition of angiotensin receptor blockade superior to increasing ACE inhibitor dose in patients with heart failure?
    Brack J; Sindone A; Funston R; Schneider H; Skiba M; Ueng KC; Krum H
    Int J Cardiol; 2010 Mar; 139(3):309-12. PubMed ID: 19027970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usual ACE inhibitor therapy in CKD patients is associated with lower plasma aldosterone levels than usual angiotensin receptor blocker therapy.
    Haddad N; Rajan J; Nagaraja HN; Agarwal AK; Hebert LA
    Kidney Blood Press Res; 2007; 30(5):299-305. PubMed ID: 17641546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy.
    Chatzikyriakou SV; Tziakas DN; Chalikias GK; Stakos D; Thomaidi A; Mitrousi K; Boudoulas H
    Eur J Pharmacol; 2010 Feb; 628(1-3):164-70. PubMed ID: 19958769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of enalaprilat in chronic therapy of heart failure: relationship to adverse events.
    Brunner-La Rocca HP; Weilenmann D; Kiowski W; Maly FE; Follath F
    J Pharmacol Exp Ther; 1999 Apr; 289(1):565-71. PubMed ID: 10087051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure?
    MacFadyen RJ; Lee AF; Morton JJ; Pringle SD; Struthers AD
    Heart; 1999 Jul; 82(1):57-61. PubMed ID: 10377310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving practice patterns in heart failure through a national cardiological network: the case of ACE-inhibitors.
    Porcu M; Opasich C; Scherillo M; Lucci D; De Maria R; Di Tano G; Maggioni AP;
    Ital Heart J; 2002 Dec; 3(12):730-7. PubMed ID: 12611125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
    Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
    Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction.
    Di Pasquale P; Cannizzaro S; Scalzo S; Parrinello G; Fasullo S; Giambanco F; Fatta A; Paterna S
    Am Heart J; 2005 Nov; 150(5):919. PubMed ID: 16290961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerability and efficacy of aldosterone inhibition with canrenone in heart failure: the real-world experience of an outpatient heart failure clinic].
    Nassiacos D; Meloni S
    Ital Heart J; 2005 May; 6 Suppl 1():51S-65S. PubMed ID: 15945300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can treatment with angiotensin-converting enzyme inhibitors in elderly patients with moderate to severe chronic heart failure be improved by a nurse-monitored structured care program? A randomized controlled trial.
    Ekman I; Fagerberg B; Andersson B; Matejka G; Persson B
    Heart Lung; 2003; 32(1):3-9. PubMed ID: 12571543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
    Willenheimer R; van Veldhuisen DJ; Silke B; Erdmann E; Follath F; Krum H; Ponikowski P; Skene A; van de Ven L; Verkenne P; Lechat P;
    Circulation; 2005 Oct; 112(16):2426-35. PubMed ID: 16143696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.